Mai Capital Management Maia Biotechnology, Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Mai Capital Management holds 675 shares of MAIA stock, worth $1,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
675
Previous 675
-0.0%
Holding current value
$1,228
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
1.49MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA650KShares$1.18 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN237KShares$431,9870.19% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$390,2750.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$142,9080.0% of portfolio
-
Centric Wealth Management68.2KShares$124,2110.03% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $19.9M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...